Verrucous herpes of the scrotum in a human immunodeficiency virus-positive man: Case report and review of the literature

Journal of the European Academy of Dermatology and Venereology

Volumn 16, Issue 5, 2002, Pages 511-515

  Carrasco, D A ^a   Trizna, Z ^b   Colome Grimmer, M ^c   Tyring, S K ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

^c Department of Dermatology ^*

Author keywords

Genital herpes; Verrucous herpes

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; VALACICLOVIR;

ADULT; ARTICLE; CASE REPORT; CONDYLOMA; CONDYLOMA ACUMINATUM; DIFFERENTIAL DIAGNOSIS; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MEDICAL LITERATURE; PRIORITY JOURNAL; PRISON; RECURRENT DISEASE; SCROTUM DISORDER; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TREATMENT OUTCOME; VIRUS CULTURE; VIRUS LOAD;

ACYCLOVIR; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; HERPES GENITALIS; HUMANS; MALE; SCROTUM; VALINE;

EID: 0036750606     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2002.00500.x     Document Type: Article

References (42)

1. Kinghorn GR. Genital herpes: Natural history and treatment of acute episodes. J Med Virol Suppl 1993; 1: 33-38.
2. Siegal FP, Lopez C, Hammer GS et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981; 305: 1439-1444.
3. Tyring SK, Carlton SS, Evans T. Herpes, atypical clinical manifestations. Dermatol Clinics 1998; 16: 783-788.
4. Centers for Disease Control and Prevention. Guidelines for the treatment of sexually transmitted diseases. MMWR 1998; 47(RR-1): 1- 116.
5. Schomogyi M, Wald A, Corey L. Herpes simplex virus-2 infection. An emerging disease? Infect Dis Clin North Am 1998; 12: 47-61.
6. Czelusta A, Yen-Moore A, Vander Straten M et al. An overview of sexually transmitted diseases (STDs) Part III. STDs in human immunodeficiency virus-infected patients. J Am Acad Dermatol 2000; 43(3): 409-432.
7. Quinnan G, Masur H, Rook AH et al. Herpesvirus infections in the acquired immunodeficiency syndrome. JAMA 1984; 252: 72-77.
8. Maier J, Bergman A, Ross M. Acquired immunodeficiency syndrome manifested by chronic primary genital herpes. Am J Obstet Gynecol 1986; 155: 756-758.
9. Skinhoj P. Herpesvirus infections in the immunocompromised patient. Scand J Infect Dis 1985; 47 (Suppl.): 121-127.
10. Bagdades E, Pillay D, Squire S et al. Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. AIDS 1992; 6: 1317-1320.
11. Kalb R, Grossman M. Chronic perianal herpes simplex in immunocompromised host. Am J Med 1986; 80: 486.
12. Centers for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41: 1-19.
13. Tayal SC, Pattman RS, McLelland J et al. An indolent penile herpetic ulcer in a patient with previously undiagnosed human immunodeficiency virus infection. Br J Dermatol 1998; 138: 334-336.
14. Schacker T, Hu H, Koelle DM et al. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons: a double-blind, placebo-controlled trial. Ann Intern Med 1998; 128: 21-28.
15. Lawrence A, Bell A. Valacyclovir for prevention of recurrent herpes virus infection in HIV-infected individuals - A double blind controlled trial. 8th European Congress of Clinical Microbiology and Infectious Diseases, May 25-28, Lausanne, Switzerland, 1997.
16. Augenbraun MH, McCormack WM. Sexually transmitted diseases in HIV-infected persons. Infect Dis Clin North Am 1994; 8: 439-448.
17. Pereira FA. Herpes simplex: Evolving concepts. J Am Acad Dermatol 1996; 35: 503-520.
18. Ioannidis J, Collier A, Cooper D et al. Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis 1998; 178: 349-359.
19. Douglas JM, Critchlow C, Benedetti J et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984; 310: 1551-1556.
20. Strauss SE, Takiff HE, Seidlin M et al. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med 1984; 310: 1545-1550.
21. Locke L, Young C, Saltzman R. Famciclovir safety experience in long-term treatment and in immunocompromised patients. 8th International Congress on Infectious Diseases, May 15-18, Boston, MA, 1998.
22. Burnside A, Preston R, Crann R, Young C. Famciclovir for suppression of recurrent genital herpes in HIV-infected patients, 36th Annual Meeting of the Infectious Disease Society of America, November 12-15, Denver, CO, 1998.
23. Safrin S, Cherrington J, Jaffe HS. Clinical uses of cidofovir. Rev Med Virol 1997; 7: 145-156.
24. Safrin S, Kemmerly S, Plotkin B et al. Foscarnet resistant herpes simplex virus infection in patients with AIDS. J Infect Dis 1994; 169: 193-196.
25. Snoeck R, Andrei G, Gerard M et al. Successful treatment of progressive mucocutaneous infection due to acyclovir and foscarnet resistant herpes simplex virus with (S)-1-(3-hydroxy2phosphonylmethoxypropyl) cytosine (HPMPC). Clin Infect Dis 1994; 18: 570-578.
26. Sacks SL, Shafran SD, Diaz-Mitoma F et al. A multicenter phaseI/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes. Antimicrob Agents Chemother 1998; 42: 2996-2999.
27. Tong P, Mutasim D. Herpes simplex virus infection masquerading as condyloma acuminata in a patient with HIV disease. Br J Dermatol 1996; 134: 797-800.
28. Smith K, Skelton H, Frissman D, Angritt P. Verrucous lesions secondary to DNA viruses in patients infected with the human immunodeficiency virus in association with increased factor XIIIa-positive dermal dendritic cells. J Am Acad Dermatol 1992; 27: 943-950.
29. Horner P, Harris J. A herpes simplex skin ulcer in a patient with AIDS. An unusual presentation. Int J STD AIDS 1990; 1: 288-289.
30. Gretzula J, Penneys N. Complex viral and fungal skin lesions of patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1987; 16: 1151-1154.
31. Smith K, Skelton H, James W, Angritt I. Concurrent epidermal involvement of cytomegalovirus and herpes simplex virus in two HIV-infected patients. J Am Acad Dermatol 1991; 25: 500-506.
32. Husak R, Tebbe B, Goerdt S et al. Pseudotumor of the tongue caused by herpes simplex virus type 2 in an HIV-1 infected immunosuppressed patient. Br J Dermatol 1998; 139: 118-121.
33. Nelson J, Ghazal P, Wiley C. Role of opportunistic viral infections in AIDS. AIDS 1990; 4: 1-10.
34. Mole L, Ripich S, Margolis D, Holodnif M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997; 176: 766-770.
35. Gallant JE, Moore RD, Keruly J et al. Zidovudine epidemiology study group: Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1995; 172: 346-352.
36. Stein DS, Graham NMH, Park LP et al. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Ann Intern Med 1995; 121: 100-108.
37. Englund JA, Zimmerman ME, Swierkosz EM et al. Herpes simplex virus resistant to acyclovir: a study in a tertiary care center. Ann Intern Med 1990; 112: 416-422.
38. Golden M, Kim S, Hammer S et al. Activation of human immunodeficiency virus by herpes simplex virus. J Infect Dis 1992; 166: 494-499.
39. Griffiths P. Studies to define viral cofactors for human immunodeficiency virus. Infect Agents Dis 1992; 1: 237-244.
40. Kucera L, Leake E, Iyer N et al. Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4 cell: Effect of coinfection on infectious HSV-2 and HIV-1 replication. AIDS Res Hum Retroviruses 1990; 6: 641-647.
41. Erlich K, Mills J, Chatis P et al. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989; 320: 293-296.
42. Severson JL, Tyring SK. The interrelationships between herpes simplex viruses and human immunodeficiency virus infections. Arch Dermatol 1999; 135: 1393-1397.